Ascend Wellness Posts Strong 2025 Results Amid Arbitration Dispute
Event summary
- Ascend Wellness Holdings (AWH) reported preliminary Q4 2025 revenue of ~$120M and FY 2025 revenue of ~$500M.
- Adjusted EBITDA margins expanded to ~25% in Q4 2025 and ~23% for FY 2025.
- AWH ended 2025 with $86M in cash and no significant debt maturities until 2029.
- Company received an unfavorable arbitration award from Green Thumb Industries (GTI) on February 5, 2026.
The big picture
AWH's strong financial performance in 2025 underscores its strategic shift toward a customer-focused CPG model, driving market share gains in core states. However, the arbitration dispute with GTI introduces uncertainty, testing the company's financial resilience and operational agility in a competitive multi-state cannabis landscape.
What we're watching
- Financial Flexibility
- Whether AWH's $86M cash position and lack of debt maturities until 2029 will provide sufficient buffer against potential arbitration liabilities.
- Market Expansion
- The pace at which AWH advances its expansion pipeline and M&A initiatives under its disciplined growth strategy.
- Operational Efficiency
- How AWH sustains its improved Adjusted EBITDA margins amid broader market pressures in the cannabis sector.
Related topics